This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Activity Details
| 645 * | Thu, 8/5/2010, 10:30 AM - 12:20 PM | CC-301 (West) |
| Key Multiplicity Issues in Clinical Trials — Invited Papers | ||
| Biopharmaceutical Section , Committee on Applied Statisticians , ENAR | ||
| Organizer(s): Alex Dmitrienko, Eli Lilly and Company | ||
| Chair(s): Yan Daniel Zhao, Eli Lilly and Company | ||
| 10:35 AM | Regulatory Considerations for Addressing Multiplicity Problems of Clinical Trials with Multiple Endpoints — Mohammad F. Huque, FDA | |
| 11:00 AM | Industry Perspective on the FDA Guidance on Multiplicity Issues — Walter W. Offen, Eli Lilly and Company | |
| 11:25 AM | Variations of and Types of Statistical Control for Multiplicity in Clinical Trials: The Academic Perspective — Joseph Massaro, Boston University ; Ralph B. D'Agostino, Sr., Boston University | |
| 11:50 AM | Multiplicity in Clinical Trials: A European Perspective — Norbert Benda, BfArM ; Joachim Roehmel , Institute for Prevention Research and Social Medicine | |
| 12:15 PM | Floor Discussion | |
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.